KPV

KPV is lysine-proline-valine, the three C-terminal residues of alpha-melanocyte stimulating hormone. The interesting property is dissociation: the anti-inflammatory activity of alpha-MSH appears to survive truncation to this tripeptide, while the melanocortin receptor binding responsible for pigmentation effects does not. That makes KPV a tool for asking which alpha-MSH effects require receptor engagement at all — some of the published mechanism points toward intracellular action on NF-κB signalling rather than surface receptor binding.

It is a three-residue peptide, so synthesis is trivial and purity is rarely the problem. The genuine quality risk is that a tripeptide is cheap enough that nobody bothers to verify it, and mislabelled or under-filled vials go unnoticed. We run the same release panel on it as on a 40-mer.